Inlybest 5 mg Tablet
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Inlybest 5 mg Tablet contains axitinib, a tyrosine kinase inhibitor. Its labelling describes it for the treatment of kidney cancer, among other cancers. It is described as blocking the action of abnormal proteins that signal cancer cells to multiply, slowing or stopping the spread of cancer cells. It can be taken with or without food but should be taken at the same time each day; the dose may change as the condition progresses, and the benefits can take over a month to become visible, so it should not be stopped until the doctor advises.
Product Information
The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the treatment of kidney cancer
- Also listed for pancreatic cancer, small cell and non-small cell lung cancer, liver cancer, thyroid cancer, blood cancer (chronic myeloid leukaemia), gastrointestinal stromal tumour, cancer of the colon and rectum, soft tissue sarcoma, chronic idiopathic myelofibrosis, and breast cancer
- Described as blocking abnormal proteins that signal cancer cells to multiply, slowing or stopping their spread
Described Dosage & Administration
- Taken by mouth following the doctor’s instructions on dosage and interval
- Swallowed whole; not chewed, crushed, or broken
- Taken at a fixed time, with or without food; the dose may change as the condition progresses
- Benefits can take over a month to become visible; it should not be stopped until the doctor advises
Described Side Effects
Commonly described side effects include:
- Fatigue and weakness
- High blood pressure
- Dizziness
- Nausea and vomiting
- Dry skin
- Constipation
- Decreased appetite
- Muscle pain
- Anaemia
- Headache
- Weight loss
- Dehydration
These are described as commonly temporary. The doctor should be consulted if they bother the patient or persist.
Precautions
- A complete medical history and current medicines should be shared with the doctor
- The doctor should be informed beforehand of thyroid issues, medicines for infection, liver issues, or bleeding issues
- Described as not highly recommended during pregnancy or breastfeeding
- All female patients should use effective contraception to avoid pregnancy, as it can harm the baby
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains axitinib and is used for the treatment of kidney cancer, among other cancers. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as swallowed whole at a fixed time each day, with or without food, following the doctor’s instructions; the dose may change with the condition and it should not be stopped until the doctor advises.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.